Follow
Anne Mai Wassermann
Anne Mai Wassermann
Computational Molecular Design, Bayer
Verified email at bayer.com
Title
Cited by
Cited by
Year
Activity landscape representations for structure− activity relationship analysis
AM Wassermann, M Wawer, J Bajorath
Journal of medicinal chemistry 53 (23), 8209-8223, 2010
1732010
Dark chemical matter as a promising starting point for drug lead discovery
AM Wassermann, E Lounkine, D Hoepfner, G Le Goff, FJ King, C Studer, ...
Nature chemical biology 11 (12), 958-966, 2015
1132015
SARANEA: a freely available program to mine structure− activity and structure− selectivity relationship information in compound data sets
E Lounkine, M Wawer, AM Wassermann, J Bajorath
Journal of chemical information and modeling 50 (1), 68-78, 2010
832010
Ligand prediction for orphan targets using support vector machines and various target-ligand kernels is dominated by nearest neighbor effects
AM Wassermann, H Geppert, J Bajorath
Journal of chemical information and modeling 49 (10), 2155-2167, 2009
752009
Data structures and computational tools for the extraction of SAR information from large compound sets
M Wawer, E Lounkine, AM Wassermann, J Bajorath
Drug Discovery Today 15 (15-16), 630-639, 2010
712010
BindingDB and ChEMBL: online compound databases for drug discovery
AM Wassermann, J Bajorath
Expert opinion on drug discovery 6 (7), 683-687, 2011
702011
Chemical substitutions that introduce activity cliffs across different compound classes and biological targets
AM Wassermann, J Bajorath
Journal of chemical information and modeling 50 (7), 1248-1256, 2010
692010
Searching for target-selective compounds using different combinations of multiclass support vector machine ranking methods, kernel functions, and fingerprint descriptors
AM Wassermann, H Geppert, J Bajorath
Journal of chemical information and modeling 49 (3), 582-592, 2009
652009
Entourage: Visualizing relationships between biological pathways using contextual subsets
A Lex, C Partl, D Kalkofen, M Streit, S Gratzl, AM Wassermann, ...
IEEE transactions on visualization and computer graphics 19 (12), 2536-2545, 2013
622013
SAR matrices: automated extraction of information-rich SAR tables from large compound data sets
AM Wassermann, P Haebel, N Weskamp, J Bajorath
Journal of chemical information and modeling 52 (7), 1769-1776, 2012
612012
Biodiversity of small molecules–a new perspective in screening set selection
PM Petrone, AM Wassermann, E Lounkine, P Kutchukian, B Simms, ...
Drug discovery today 18 (13-14), 674-680, 2013
602013
Design of multitarget activity landscapes that capture hierarchical activity cliff distributions
D Dimova, M Wawer, AM Wassermann, J Bajorath
Journal of chemical information and modeling 51 (2), 258-266, 2011
522011
Public domain HTS fingerprints: design and evaluation of compound bioactivity profiles from PubChem’s bioassay repository
KY Helal, M Maciejewski, E Gregori-Puigjane, M Glick, AM Wassermann
Journal of chemical information and modeling 56 (2), 390-398, 2016
502016
Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs
AM Wassermann, J Bajorath
Future Medicinal Chemistry 3 (4), 425-436, 2011
502011
Pathfinder: Visual analysis of paths in graphs
C Partl, S Gratzl, M Streit, AM Wassermann, H Pfister, D Schmalstieg, ...
Computer Graphics Forum 35 (3), 71-80, 2016
492016
Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families
Y Hu, AM Wassermann, E Lounkine, J Bajorath
Journal of medicinal chemistry 53 (2), 752-758, 2010
472010
Composition and applications of focus libraries to phenotypic assays
AM Wassermann, LM Camargo, DS Auld
Frontiers in Pharmacology 5, 164, 2014
452014
A screening pattern recognition method finds new and divergent targets for drugs and natural products
AM Wassermann, E Lounkine, L Urban, S Whitebread, S Chen, K Hughes, ...
ACS chemical biology 9 (7), 1622-1631, 2014
372014
Comprehensive analysis of single‐and multi‐target activity cliffs formed by currently available bioactive compounds
AM Wassermann, D Dimova, J Bajorath
Chemical biology & drug design 78 (2), 224-228, 2011
342011
Large scale meta-analysis of fragment-based screening campaigns: privileged fragments and complementary technologies
PS Kutchukian, AM Wassermann, MK Lindvall, SK Wright, J Ottl, J Jacob, ...
Journal of biomolecular screening 20 (5), 588-596, 2015
322015
The system can't perform the operation now. Try again later.
Articles 1–20